In a Defensive regime, IONS's AIQ Score of 30/100 with Quality base of 30/100 and accelerating Momentum at 22/100 (Δ+7) suggests caution. Reduce position size or hold. Confirm reversal before re-entering.
Quick Stats
IONS's 7-day signal profile is improving with AIQ change of +2.0 points and momentum delta of +7.0. Trend delta is +2.00, which helps frame whether the current move is accelerating or fading.
Snapshot: Sun, 26 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.
| Date | AIQ | Mom | Val | Qual | Resilience |
|---|---|---|---|---|---|
| 2026-07-25 | 30 | 22 | 34 | 30 | 32 |
| 2026-07-18 | 28 | 15 | 34 | 30 | 32 |
| 2026-07-11 | 29 | 21 | 34 | 30 | 32 |
| 2026-07-04 | 47 | 81 | 34 | 30 | 51 |
| 2026-06-27 | 47 | 81 | 34 | 30 | 50 |
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
IONS (IONS) Stock Analysis
IONS (IONS) has an AIQ Score of 30/100 in a Defensive regime as of Jul 25, 2026. Value is strongest at 34/100. Momentum is weakest at 22/100. The main conflict is that value leads at 34/100 while momentum lags at 22/100.
IONS (IONS) carries an AIQ Score of 30 out of 100, placing it in a bearish signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 0.36, implying roughly 64% lower sensitivity than a broad market baseline.
In the latest weekly profile, AIQ has moved +2.0 points over the last 7 days, momentum delta is +7.0, trend delta is +2.00, risk delta is 0.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | IONS is in a Defensive AIQ regime with score 30/100. |
| Signal Conflict | The primary conflict is that value leads at 34/100 while momentum lags at 22/100. |
| Factor Evidence | Momentum 22/100 · Value 34/100 · Quality 30/100 · Risk 32/100 |
| Persistence | IONS has scored AIQ 60+ in 0 of the last 60 daily snapshots. 30-day avg: 38/100. 60-day avg: 38/100. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Fail | Value is the strongest factor at 34/100. |
| Timing | Fail | Momentum is 22/100 with 7-day delta +7.0. |
| Regime fit | Fail | IONS is in a Defensive regime at 30/100. |
| Risk control | Pass | Risk factor is 32/100 with beta of 0.36 implies lower sensitivity than the broader market. |
| Conflict | Pass | Current conflict: value leads at 34/100 while momentum lags at 22/100. |
IONS's 7-day signal profile is improving with AIQ change of +2.0 points and momentum delta of +7.0. Trend delta is +2.00, which helps frame whether the current move is accelerating or fading.
Signal snapshot as of Sun, 26 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.
| Metric | Current |
|---|---|
| AIQ Score | 30/100 |
| Price | $56.55 |
| Beta | 0.36 |
IONS vs Gene Editing / Genomics / Biotech Peers
Portfolio Implication
Related Links
IONS Stock FAQ
What does the IONS AIQ Score mean?
AIQ Score summarizes multiple factors for IONS, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is IONS data updated?
IONS quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare IONS with an index before investing?
Yes. Comparing IONS versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper IONS fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading IONS...